Actavis Launches Alprazolam ER Tablets In The U.S.
Thu, 15 Feb 2007 08:00 AM EST
... Actavis Group (ICEX: ACT), the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Alprazolam ER tablets. Distribution of the product will commence in coming weeks. Alprazolam ER tablets, the generic equivalent of Pfizer's Xanax(R) XR tablets, will be available in 0. [click link for full article] ...
Related Topics
- Alprazolam
- Alprazolam Oral Solution
- Carbinoxamine and Pseudoephedrine Tablets
- Albuterol Oral Tablets
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Nitroglycerin Buccal ER Tablets
- Methylphenidate ER
- Cyanocobalamin Tablets
- Divalproex
- Metronidazole Extended Release
- Niacin Extended Release
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Neostigmine Tablets
- Haloperidol Tablets
- Thiabendazole Tablets
- Glipizide
- Carbetapentane, Phenylephrine, and Pyrilamine
- Ergoloid Mesylates Sublingual Tablets
- Nystatin Tablets

Not Signed In -

